Insulet Corp.
PODD
Rank in Stocks
#2101
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Share Price
$141.45
Market Cap
$9.81B
Change (1 day)
0.25%
Change (1 year)
-55.60%
Country
US
Trade Insulet Corp. (PODD)
Category
Healthcare
Number of shares outstanding for Insulet Corp. (PODD)
Number of shares outstanding as of June 2026: 69.30M
According to Insulet Corp. latest financial reports and stock price the company's current number of shares outstanding is 69.30M. At the end of December 2023 the company had 69.75M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Insulet Corp. (PODD) from 2002 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 69.30M | -1.11% |
| 2024 | 70.08M | 0.47% |
| 2023 | 69.75M | 0.54% |
| 2022 | 69.38M | 2.48% |
| 2021 | 67.70M | 4.58% |
| 2020 | 64.74M | 6.83% |
| 2019 | 60.59M | 2.95% |
| 2018 | 58.86M | 1.48% |
| 2017 | 58.00M | 2.32% |
| 2016 | 56.69M | -0.17% |
| 2015 | 56.79M | 2.08% |
| 2014 | 55.63M | 3.00% |
| 2013 | 54.01M | 12.70% |
| 2012 | 47.92M | 2.64% |
| 2011 | 46.69M | 17.88% |
| 2010 | 39.61M | 33.24% |
| 2009 | 29.73M | 7.66% |
| 2008 | 27.61M | 65.45% |
| 2007 | 16.69M | 1,719.35% |
| 2006 | 917.28K | 200.78% |
| 2005 | 304.96K | 5.11% |
| 2004 | 290.14K | 6.62% |
| 2003 | 272.12K | -8.49% |
| 2002 | 297.38K | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 1.74B | 2,415.30% |
US
|
|
| 1.28B | 1,750.13% |
IE
|
|
| 383.50M | 453.41% |
US
|
|
| 1.48B | 2,032.24% |
US
|
|
| - | - |
DE
|
